Grace Therapeutics, Stock Alpha and Beta Analysis
| GRCE Stock | 3.58 0.32 8.21% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Grace Therapeutics,. It also helps investors analyze the systematic and unsystematic risks associated with investing in Grace Therapeutics, over a specified time horizon. Remember, high Grace Therapeutics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Grace Therapeutics,'s market risk premium analysis include:
Beta 0.049 | Alpha 0.91 | Risk 5.08 | Sharpe Ratio 0.12 | Expected Return 0.63 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Grace |
Grace Therapeutics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Grace Therapeutics, market risk premium is the additional return an investor will receive from holding Grace Therapeutics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Grace Therapeutics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Grace Therapeutics,'s performance over market.| α | 0.91 | β | 0.05 |
Grace Therapeutics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Grace Therapeutics,'s Buy-and-hold return. Our buy-and-hold chart shows how Grace Therapeutics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Grace Therapeutics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Grace Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Grace Therapeutics, shares will generate the highest return on investment. By understating and applying Grace Therapeutics, stock market price indicators, traders can identify Grace Therapeutics, position entry and exit signals to maximize returns.
Grace Therapeutics, Return and Market Media
The median price of Grace Therapeutics, for the period between Mon, Sep 16, 2024 and Sun, Dec 15, 2024 is 3.21 with a coefficient of variation of 13.23. The daily time series for the period is distributed with a sample standard deviation of 0.43, arithmetic mean of 3.23, and mean deviation of 0.29. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - StockTitan | 10/25/2024 |
2 | GRCE - Grace Therapeutics, Inc. Latest Stock News Market Updates - StockTitan | 10/30/2024 |
3 | Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update | 11/13/2024 |
4 | GRCE Total Inventories 0.00 Mil - GuruFocus.com | 11/20/2024 |
5 | GRCE aSAH KOL Summary | 12/11/2024 |
About Grace Therapeutics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Grace or other stocks. Alpha measures the amount that position in Grace Therapeutics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Grace Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Grace Therapeutics,'s short interest history, or implied volatility extrapolated from Grace Therapeutics, options trading.
Build Portfolio with Grace Therapeutics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Grace Therapeutics, Backtesting, Grace Therapeutics, Valuation, Grace Therapeutics, Correlation, Grace Therapeutics, Hype Analysis, Grace Therapeutics, Volatility, Grace Therapeutics, History and analyze Grace Therapeutics, Performance. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.